{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:01:25Z","timestamp":1772010085025,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T00:00:00Z","timestamp":1447459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Gilead Sciences GmbH","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10620-015-3960-x","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T11:56:03Z","timestamp":1447502163000},"page":"3061-3071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany"],"prefix":"10.1007","volume":"61","author":[{"given":"J\u00f6rg","family":"Petersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Heyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Mauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Schlaak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willibald","family":"Schiffelholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Eisenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Boeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns-Friedrich","family":"Loehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Leuschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Felten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Trein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Warger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Hueppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"3960_CR1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","volume":"359","author":"P Marcellin","year":"2008","unstructured":"Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 2008;359:2442\u20132455.","journal-title":"N Engl J Med"},{"key":"3960_CR2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468\u2013475.","journal-title":"Lancet"},{"key":"3960_CR3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.26686","volume":"59","author":"KM Kitrinos","year":"2014","unstructured":"Kitrinos KM, Corsa A, Liu Y, et al. No detectable resistance to tenofovir disoproxil fumarate after 6\u00a0years of therapy in patients with chronic hepatitis B. Hepatology. 2014;59:434\u2013442.","journal-title":"Hepatology"},{"key":"3960_CR4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1053\/j.gastro.2013.12.028","volume":"146","author":"S Fung","year":"2014","unstructured":"Fung S, Kwan P, Fabri M, et al. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with\u00a0lamivudine-resistant chronic hepatitis B. Gastroenterology. 2014;146:980\u2013988.","journal-title":"Gastroenterology"},{"key":"3960_CR5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/j.gastro.2010.06.053","volume":"139","author":"T Berg","year":"2010","unstructured":"Berg T, Marcellin P, Zoulim F, et al. Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. Gastroenterology. 2010;139:1207\u20131217.","journal-title":"Gastroenterology"},{"key":"3960_CR6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.2010.223206","volume":"60","author":"SJ Patterson","year":"2011","unstructured":"Patterson SJ, George J, Strasser SI, et al. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut. 2011;60:247\u2013254.","journal-title":"Gut"},{"key":"3960_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2893.2011.01533.x","volume":"19","author":"CQ Pan","year":"2012","unstructured":"Pan CQ, Hu KQ, Yu AS, et al. Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir. J Viral Hepatitis. 2012;19:213\u2013219.","journal-title":"J Viral Hepatitis"},{"key":"3960_CR8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.23952","volume":"53","author":"YF Liaw","year":"2011","unstructured":"Liaw YF, Sheen IS, Lee CM, et al. Tenofovir disoproxil fumarate (TDF), emtricitabine\/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease. Hepatology. 2011;53:62\u201372.","journal-title":"Hepatology"},{"key":"3960_CR9","unstructured":"Lampertico P, Soffredini R, Yurdaydin C, et al. Four years of TDF for NUC na\u00efve field practice European patients suppress HBV replication in most patients with a favorable renal safety profile but do not prevent HCC in patients with or without cirrhosis. Presented at AASLD, Washington DC, USA, November 1\u20135, 2013; poster 933."},{"key":"3960_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","volume":"51","author":"F B\u00f6mmel van","year":"2010","unstructured":"van B\u00f6mmel F, deMan RA, Wedemeyer H, et al. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues. Hepatology. 2010;51:73\u201380.","journal-title":"Hepatology"},{"key":"3960_CR11","unstructured":"van B\u00f6mmel F, de Man RA, Rutter R, et al. A European multicenter analysis of long term tenofovir (TDF) monotherapy for chronic hepatitis B in real life setting: efficacy, safety and HCC incidence. Presented at AASLD, Washington DC, USA, November 1\u20135, 2013; poster 941."},{"key":"3960_CR12","unstructured":"Levrero M, Cimino L, Lampertico P, et al. OptiB\u2014A multicenter prospective open label study on Tenofovir (TDF) for chronic hepatitis B patients with suboptimal response to adefovir (ADV) or ADV\/LAM treatment. Presented at EASL, Berlin, Germany, March 30\u2013April 3, 2011; poster 732."},{"key":"3960_CR13","unstructured":"Lim L, Patterson S, George J, et al. Tenofovir rescue therapy achieves long-term suppression of HBV replication in patients with multi-drug resistant HBV: 5\u00a0year follow-up of the TDF109 cohort. Presented at AASLD, Boston MA, USA, November 9\u201313, 2012; poster 361."},{"key":"3960_CR14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2011.09.018","volume":"56","author":"J Peterson","year":"2012","unstructured":"Peterson J, Ratziu V, Buti M, et al. Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J Hepatol. 2012;56:520\u2013526.","journal-title":"J Hepatol"},{"key":"3960_CR15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2893.2012.01602.x","volume":"19","author":"S Pol","year":"2012","unstructured":"Pol S, Lampertico P. First-line treatment of chronic hepatitis B with entecavir or tenofovir in \u201creal-life\u201d settings: from clinical trials to clinical practice. J Viral Hepatitis. 2012;19:377\u2013386.","journal-title":"J Viral Hepatitis"},{"key":"3960_CR16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1055\/s-0031-1273462","volume":"49","author":"M Cornberg","year":"2011","unstructured":"Cornberg M, Protzer U, Petersen J, et al. Aktualisierung der s3-leitlinie zur prophylaxe, diagnostik und therapie der hepatitis-b-virusinfektion. Z Gastroenterol. 2011;49:871\u2013930.","journal-title":"Z Gastroenterol"},{"key":"3960_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"EASL","year":"2012","unstructured":"EASL. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167\u2013185.","journal-title":"J Hepatol"},{"key":"3960_CR18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","volume":"130","author":"UH Iloeje","year":"2006","unstructured":"Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678\u2013686.","journal-title":"Gastroenterology"},{"key":"3960_CR19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/gutjnl-2012-302024","volume":"62","author":"R Zoutendik","year":"2013","unstructured":"Zoutendik R, Rejinders GP, Zoulim F, et al. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis. Gut. 2013;62:760\u2013765.","journal-title":"Gut"},{"key":"3960_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2893.2005.00603.x","volume":"12","author":"HJ Yuan","year":"2005","unstructured":"Yuan HJ, Yuen MF, Ka-Ho WD, Sablon E, Lai CL. The relationship between HBV\u2013DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B. J Viral Hepatol.. 2005;12:373\u2013379.","journal-title":"J Viral Hepatol."},{"key":"3960_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02942173","volume":"6","author":"CJ Chen","year":"2007","unstructured":"Chen CJ, Iloeje UH, Yang HI. Serum hepatitis B virus DNA as a predictor of the development of cirrhosis and hepatocellular carcinoma. Curr Hepatol Rep. 2007;6:9\u201316.","journal-title":"Curr Hepatol Rep"},{"key":"3960_CR22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","volume":"140","author":"EJ Heathcote","year":"2011","unstructured":"Heathcote EJ, Marcellin P, Buti M, et al. Three year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011;140:132\u2013143.","journal-title":"Gastroenterology"},{"key":"3960_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfq128","volume":"116","author":"E Lock","year":"2010","unstructured":"Lock E. Sensitive and early markers of renal injury: where are we and what is the way forward? Toxicol Sci. 2010;116:1\u20134.","journal-title":"Toxicol Sci"},{"key":"3960_CR24","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s10620-014-3230-3","volume":"59","author":"PJ Tsai","year":"2014","unstructured":"Tsai PJ, Chang A, Yamada S, Tsai N, Bartholomew ML. Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women. Dig Dis Sci. 2014;59:2797\u20132803.","journal-title":"Dig Dis Sci"},{"key":"3960_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2014.04.038","volume":"61","author":"AJ Greenup","year":"2014","unstructured":"Greenup AJ, Tan PK, Nguyen V, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol. 2014;61:502\u2013507.","journal-title":"J Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3960-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3960-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3960-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:49:57Z","timestamp":1559245797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3960-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3960"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3960-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,14]]}}}